Correlation Between MAIA Biotechnology and Burzynski Research
Can any of the company-specific risk be diversified away by investing in both MAIA Biotechnology and Burzynski Research at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MAIA Biotechnology and Burzynski Research into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MAIA Biotechnology and Burzynski Research, you can compare the effects of market volatilities on MAIA Biotechnology and Burzynski Research and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MAIA Biotechnology with a short position of Burzynski Research. Check out your portfolio center. Please also check ongoing floating volatility patterns of MAIA Biotechnology and Burzynski Research.
Diversification Opportunities for MAIA Biotechnology and Burzynski Research
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between MAIA and Burzynski is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding MAIA Biotechnology and Burzynski Research in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Burzynski Research and MAIA Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MAIA Biotechnology are associated (or correlated) with Burzynski Research. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Burzynski Research has no effect on the direction of MAIA Biotechnology i.e., MAIA Biotechnology and Burzynski Research go up and down completely randomly.
Pair Corralation between MAIA Biotechnology and Burzynski Research
Given the investment horizon of 90 days MAIA Biotechnology is expected to under-perform the Burzynski Research. But the stock apears to be less risky and, when comparing its historical volatility, MAIA Biotechnology is 2.31 times less risky than Burzynski Research. The stock trades about -0.19 of its potential returns per unit of risk. The Burzynski Research is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 3.90 in Burzynski Research on September 3, 2024 and sell it today you would lose (0.40) from holding Burzynski Research or give up 10.26% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
MAIA Biotechnology vs. Burzynski Research
Performance |
| Timeline |
| MAIA Biotechnology |
| Burzynski Research |
MAIA Biotechnology and Burzynski Research Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MAIA Biotechnology and Burzynski Research
The main advantage of trading using opposite MAIA Biotechnology and Burzynski Research positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MAIA Biotechnology position performs unexpectedly, Burzynski Research can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Burzynski Research will offset losses from the drop in Burzynski Research's long position.| MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
| Burzynski Research vs. ProKidney Corp | Burzynski Research vs. Orchestra BioMed Holdings | Burzynski Research vs. Lixte Biotechnology Holdings | Burzynski Research vs. Oncology Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |